{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:25:29Z","timestamp":1790915129246,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.clml.2011.07.006","type":"journal-article","created":{"date-parts":[[2011,10,16]],"date-time":"2011-10-16T03:37:05Z","timestamp":1318736225000},"page":"66-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders"],"prefix":"10.1016","volume":"12","author":[{"given":"Karam M.","family":"Obeid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Szpunar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"del Busto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayad","family":"Al-Katib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2011.07.006_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1099\/0022-1317-51-7-611","article-title":"Pneumocystis carinii carriage in immuno-compromised patients with and without human immunodeficiency virus infection","volume":"51","author":"Takahashi","year":"2002","journal-title":"J Med Micobiol"},{"key":"10.1016\/j.clml.2011.07.006_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1988.03720080019021","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischi","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.clml.2011.07.006_bib3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2011.07.006_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2011.07.006_bib5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/323129","article-title":"Prevention of infection caused by Pneumocystis carinii in transplant recipients","volume":"33","author":"Fishman","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2011.07.006_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: a global perspective","volume":"44","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clml.2011.07.006_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/321805","article-title":"Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients","volume":"33","author":"Dykewicz","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2011.07.006_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1023\/A:1012551809100","article-title":"Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders","volume":"12","author":"Seymour","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2011.07.006_bib9","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V81.11.2878.2878","article-title":"Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent","volume":"11","author":"Keating","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clml.2011.07.006_bib10","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365540410021180","article-title":"Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia","volume":"36","author":"Roblot","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clml.2011.07.006_bib11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0277-5379(91)90247-B","article-title":"Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia","volume":"27","author":"Bastion","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clml.2011.07.006_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM199009203231216","article-title":"Concurrent cytomegalovirus and Pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia","volume":"323","author":"Schilling","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2011.07.006_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.2830490207","article-title":"Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancy: a role for Pneumoncystis carinii pneumonia prophylaxis","volume":"49","author":"Byrd","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2011.07.006_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/ajh.2830390418","article-title":"Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine","volume":"39","author":"Sanders","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2011.07.006_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cncr.21151","article-title":"Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with fludarabine, mitoxantrone, and dexamethasone regimen","volume":"104","author":"Tsimberidou","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2011.07.006_bib16","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/cncr.0680","article-title":"Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma","volume":"94","author":"Perkins","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2011.07.006_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-129-7-199810010-00010","article-title":"Infections in patients with chronic lymphocytic leukemia treated with fludarabine","volume":"129","author":"Anaissie","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2011.07.006_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood.V82.6.1695.1695","article-title":"Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment","volume":"82","author":"O'Brian","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clml.2011.07.006_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beha.2009.12.004","article-title":"Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches","volume":"23","author":"Morrison","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2011.07.006_bib20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.clml.2011.07.006_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0163-4453(03)00038-0","article-title":"Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study","volume":"47","author":"Roblot","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/j.clml.2011.07.006_bib22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1086\/342338","article-title":"Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study","volume":"35","author":"Zahar","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clml.2011.07.006_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years experience of infection in GIMEMA centres","volume":"117","author":"Pagano","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2011.07.006_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00365540601150497","article-title":"Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004","volume":"39","author":"Overgaard","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clml.2011.07.006_bib25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/cncr.2820360612","article-title":"Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis","volume":"36","author":"Hughes","year":"1975","journal-title":"Cancer"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011002692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011002692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:21:54Z","timestamp":1761870114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265011002692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S2152265011002692"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2011.07.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2011.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}